Related Experiment Videos
Erythema multiforme major in a 2-month-old child with human immunodeficiency virus (HIV) infection
1Clinique de Dermatologie, Hôpital Cantonal Universitaire, Geneva, Switzerland.
The British Journal of Dermatology
|December 1, 1990
Insights
A severe skin reaction, erythema multiforme, possibly triggered by phenobarbitone, occurred in an infant. The child later developed acquired immunodeficiency syndrome, suggesting congenital HIV-1 infection.
Area of Science:
- Pediatrics
- Infectious Diseases
- Dermatology
Background:
- Erythema multiforme is an acute, immune-mediated mucocutaneous reaction.
- Phenobarbitone is a known potential trigger for various adverse drug reactions.
- Congenital Human Immunodeficiency Virus (HIV) infection presents unique challenges in infants.
Observation:
- A severe case of erythema multiforme was observed in a 2-month-old male infant in Zimbabwe.
- The infant's condition was potentially precipitated by phenobarbitone exposure.
- The patient subsequently exhibited signs consistent with acquired immunodeficiency syndrome (AIDS).
Findings:
- Serological tests indicated a congenital HIV-1 infection as the underlying cause.
- The clinical presentation suggests a possible link between phenobarbitone and severe erythema multiforme in the context of congenital HIV-1.
- This case highlights a rare presentation of drug-induced skin reactions in immunocompromised infants.
Implications:
- This case underscores the importance of considering congenital HIV-1 infection in infants presenting with severe mucocutaneous reactions.
- It emphasizes the need for careful drug monitoring in pediatric patients, especially those with underlying immune deficiencies.
- Further research may elucidate the complex interplay between antiretroviral therapy, drug reactions, and immune status in vertically infected infants.
Abstract:
A case is presented of severe erythema multiforme occurring in a 2-month-old boy from Zimbabwe which was probably triggered by phenobarbitone. He later developed the acquired immunodeficiency syndrome and serological tests suggested that it was a congenital HIV-I infection.